Stimuli-responsive peptide-based nanomaterials for overcoming tumor therapy resistance
Nano Research · 10.11.2026
DOI: 10.26599/nr.2026.94909326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Research, online erschienen am 10.11.2026. Verfasst von Suyongde Zheng und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Cancer remains the leading cause of death worldwide and tumor drug resistance markedly diminishes the effectiveness of many treatments. Resistance arises not only from intrinsic factors within cancer cells but also from extrinsic mechanisms within the tumor microenvironment (TME). To address this challenge, researchers have combined stimuli-responsive peptides with nanomaterials capable of responding to endogenous or exogenous signals, thereby overcoming resistance through multiple synergistic mechanisms. This review emphasizes how rational peptide design enhances signal responsiveness and therapeutic accuracy, systematically summarizes recent advances in breaking through tumor drug resistance, and elaborates the advantages and limitations of endogenous and exogenous responsive nanomaterials. Finally, we discuss current challenges and future directions toward promoting clinical translation.
Zitieren
APA
Zheng, S., Li, X., Sun, L., Shen, J., You, H., Zhao, Y., Liu, X., Wang, W., Xu, R., Hou, D., & Wu, X. (2026). Stimuli-responsive peptide-based nanomaterials for overcoming tumor therapy resistance. Nano Research. https://doi.org/10.26599/nr.2026.94909326
Vancouver
Zheng S, Li X, Sun L, Shen J, You H, Zhao Y, et al. Stimuli-responsive peptide-based nanomaterials for overcoming tumor therapy resistance. Nano Research. 2026. doi:10.26599/nr.2026.94909326
BibTeX
@article{Zheng2026,
author = {Zheng, Suyongde and Li, Xiang-Peng and Sun, Lumin and Shen, Jingyu and You, Hui-Hui and Zhao, Yaofei and Liu, Xiao and Wang, Wenbo and Xu, Rongchen and Hou, Da-Yong and Wu, Xiu-Hai},
title = {Stimuli-responsive peptide-based nanomaterials for overcoming tumor therapy resistance},
journal = {Nano Research},
year = {2026},
doi = {10.26599/nr.2026.94909326}
}
EUVIMED